Skip to main content
Equibles

CAPITAL INTERNATIONAL LTD /CA/

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1065350 LOS ANGELES, CA
Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$8,779,840
-$841,197 QoQ
Shares Held
29,166
+0.3% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#204
of 786 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPITAL INTERNATIONAL LTD /CA/ holds $127,577,689 across 7 Biotechnology names. ALNY ranks #4 (6.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 97,334 $48,348,717
2 RPRX
Royalty Pharma plc
 579,801 $32,509,442
3 ONC
BeOne Medicines Ltd.
 77,161 $21,988,570
4 ALNY
Alnylam Pharmaceuticals, Inc.
This page 		29,166 $8,779,840
5 REGN
Regeneron Pharmaceuticals, Inc.
 13,665 $8,520,674
6 ASND
Ascendis Pharma A/S
 16,394 $4,372,607
7 CRSP
CRISPR Therapeutics AG
 56,066 $3,057,839

All Filings in ALNY

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,779,840 29,166
2026-03-31 $9,621,037 29,078
2025-12-31 $26,907,782 67,667
2025-09-30 $35,669,688 78,223
2025-06-30 $27,000,252 82,800
2025-03-31 $22,116,258 81,906
2024-12-31 $18,891,157 80,282
2024-09-30 $27,619,337 100,423
2024-06-30 $22,896,675 94,225
2024-03-31 $9,747,726 65,224
2023-12-31 $16,917,772 88,385
2023-09-30 $16,462,507 92,956
2023-06-30 $17,774,775 93,581
2023-03-31 $18,746,145 93,581
2022-12-31 $20,923,894 88,045
2022-09-30 $13,613,882 68,015
2022-06-30 $6,707,933 45,992
2022-03-31 $3,566,090 21,839